Prognostic relevance of RUNX1 mutations in T-cell acute lymphoblastic leukemia
Authors:
- V. GrossmannVGV. Grossmann
- W. KernWKW. Kern
- S. HarbichSHS. Harbich
- T. AlpermannTAT. Alpermann
- S. JerominSJS. Jeromin
- S. SchnittgerSSS. Schnittger
- C. HaferlachCHC. Haferlach
- T. HaferlachTHT. Haferlach
- A. KohlmannAKA. Kohlmann
- 9 August 2011
- journal article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 96 (12) , 1874-1877
Abstract
The runt-related transcription factor 1, RUNX1, is crucial in the development of myeloid and lymphoid cell lineages and has been reported to be mutated in myeloid malignancies in approximately 30% of cases. In this study, the mutational status of RUNX1 was investigated in 128 acute lymphoblastic leukemia patients. We detected a mutation rate of 18.3% (13 of 71) in patients with T-cell acute lymphoblastic leukemia, 3.8% (2 of 52) in patients with B-cell acute lymphoblastic leukemia and no mutation (0 of 5) in patients with natural killer cell leukemia, respectively. In T-cell acute lymphoblastic leukemia patients, RUNX1 mutations were significantly associated with higher age (P=0.017) and lower white blood cell count (P=0.038). Moreover, an inferior outcome was observed in the subgroup of early T-cell acute lymphoblastic leukemia patients carrying RUNX1 mutations for overall survival (P=0.043). In conclusion, RUNX1 mutations are an important novel biomarker for a comprehensive characterization of T-cell acute lymphoblastic leukemia with poor prognostic impact and have implications for use also in monitoring disease.Keywords
This publication has 21 references indexed in Scilit:
- RUNX1Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study GroupJournal of Clinical Oncology, 2011
- T-cell acute lymphoblastic leukemiaHaematologica, 2009
- Low ERG and BAALC Expression Identifies a New Subgroup of Adult Acute T-Lymphoblastic Leukemia With a Highly Favorable OutcomeJournal of Clinical Oncology, 2007
- Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemiaNature, 2007
- Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemiaBlood, 2004
- Validation of BIOMED-2 multiplex PCR tubes for detection of TCRB gene rearrangements in T-cell malignanciesLeukemia, 2004
- Oncogenic potential of the RUNX gene family: ‘Overview’Oncogene, 2004
- High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasiaBlood, 2004
- TREATMENT OF ADULT ALL ACCORDING TO PROTOCOLS OF THE GERMAN MULTICENTER STUDY GROUP FOR ADULT ALL (GMALL)Hematology/Oncology Clinics of North America, 2000
- Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL).1995